Dr. Christa Lynn Clark, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2220 E Bidwell St, Folsom, CA 95630 Phone: 916-983-9895 Fax: 916-983-9850 |
Dr. Shahriar Mabourakh, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1561 Creekside Dr, Suite 110, Folsom, CA 95630 Phone: 916-984-1600 Fax: 916-984-1616 |
Lauren Tracy Daly, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1841 Iron Point Rd, Folsom, CA 95630 Phone: 916-983-9895 |
Kenneth T. Sumida, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1641 Creekside Dr Ste 100, Folsom, CA 95630 Phone: 916-984-4242 |
Dr. David Lawrence Kaufman, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2220 E Bidwell St, Folsom, CA 95630 Phone: 916-983-9895 |
Dr. Terry Jay Zimmerman, MD Plastic Surgery - Surgery of the Hand Medicare: Not Enrolled in Medicare Practice Location: 2370 E Bidwell St, #100, Folsom, CA 95630 Phone: 916-983-0550 Fax: 916-983-0552 |
News Archive
Although administration officials defend the rule and some political strategists see limited political damage, the Catholic Church continues a counterattack.
s there a relation between the structure of specific regions of the brain and nicotine dependence. This is the question researchers of the Charit Universit-tsmedizin Berlin and of the Physikalisch-Technische Bundesanstalt (PTB) Berlin have been investigating lately. The results of these investigations extend and specify those of preceding studies: A specific region of the cerebral cortex of smokers is thinner than that of people who have never smoked in their lives.
A collaborative group of parent-driven organizations seeking a cure for Angelman syndrome has teamed up with F. Hoffmann-La Roche Ltd, one of the world's largest pharmaceutical and diagnostics companies, in the first phase of a study that will support the design of human clinical trials and treatment development for the disorder.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced today that it has established a Scientific Advisory Board to help advance the company's research and clinical studies in type 1 diabetes.
› Verified 3 days ago